Anna-Elina Lehtinen

Adjunct professor, Head of the unit
Coagulation Disorders Unit, Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland
Helsinki, Uusimaa, Finland

Presentation(s):

• PB0209 - Effectiveness and safety of efmoroctocog alfa (a recombinant factor VIII Fc) across body mass index (BMI) categories: pooled data from two non-interventional phase 4 studies (A-SURE/PREVENT)

  Sunday, June 23, 2024
  13:45 – 14:45 ICT